Thanatin is a natural antibiotic produced by an insect called the spined soldier bug. An interdisciplinary team of researchers from the University of Zurich found thanatin prevents Gram-negative bacteria from forming an outer membrane, which serves as a protective shield for the cells. Bacteria cannot survive without this outer membrane.
“This is an unprecedented mechanism of action for an antibiotic and immediately suggests ways to develop new molecules as antibiotics targeting dangerous pathogens,” study author John A. Robinson, PhD, a researcher in the department of chemistry at UZH, said in a press release. “This finding shows us a way to develop substances that specifically inhibit protein-protein interactions in bacterial cells.”
A Swiss drugmaker called Polyphor is already using this new mechanism to develop potential antibiotic candidates.
“Another new antibiotic targeting other Gram-negative pathogens would be a very welcome addition to the new medicines urgently needed for effective antibacterial therapy,” Dr. Robinson said.
More articles on clinical leadership and infection control:
How does caring for gun violence victims affect nurses, physicians? Researchers seek answers
Hospitals often fail to meet patients’ behavioral health needs, ECRI says
Physicians who have patient contact should have to get flu shot, most physicians say
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
